IGFBP7 together with tissue metalloproteinase 2 (TIMP2) has been extensively studied as a putative biomarker of kidney failure secondary to both diabetes and ischemia,16,17 and in heart failure.18 Here, IGFBP7 is linked to diabetes mellitus.